Mati Ullah Dad Ullah

Internal Medicine resident at the University of Oklahoma Health Sciences Center with comprehensive experience in primary care, inpatient medicine, and management of complex hospitalized patients. Dedicated physician with strong clinical judgment, multidisciplinary team experience, and commitment to evidence-based patient care. Additional background in hepatology and clinical research through dedicated research fellowship training at Beth Israel Deaconess Medical Center and Harvard Medical School.

• American Medical Association (AMA)
• American Association for the Study of Liver Diseases (AASLD)
• American College of Gastroenterology (ACG)

• Full License to Practice Medicine – Oklahoma, USA (2025–Present)
• American Board of Internal Medicine (ABIM) Eligible – August 2026
• USMLE Step 1: 259
• USMLE Step 2 CK: 271
• USMLE Step 3: 244

• Mentored incoming research fellows at Beth Israel Deaconess Medical Center
• Participated in resident and medical student teaching during inpatient rotations

• Viral hepatitis (HBV/HCV)
• Chronic liver disease
• Hepatic fibrosis biomarkers
• Outcomes research in gastroenterology

• Khan IW, Dad Ullah MU, Choudhry M, et al. Novel therapies of hepatitis B and D. Microorganisms. 2021.
• Hassam K, Raza MA, Ullah MU. The application of transient elastography for early diagnosis of pregnancy-related complications. AJOG. 2024.
• Ullah A, Wazir H, Sultany A, et al. Mortality Trends in Chronic Hepatitis C. Viruses. 2026.